Susan Cornell
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 12
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Mark H. Perrone (2 shared papers)Dilip Amin (2 shared papers)Glenda E. Bilder (1 shared paper)Curtis Triplitt (1 shared paper)Lon J. Van Winkle (2 shared papers)Sophie La Salle (2 shared papers)Susan M. Viselli (2 shared papers)Nalini Chandar (2 shared papers)
- Journals
- Journal of the American Pharmacists Association (2 papers)American Journal of Pharmaceutical Education (2 papers)Pharmacology (1 paper)Therapeutics and Clinical Risk Management (1 paper)Health Policy (1 paper)
- Partner nations
- United StatesItalyIreland
In The Last Decade
Susan Cornell
23 papers receiving 424 citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 212
- Geriatrics and Gerontology 19
- Pharmacology 55
- Orthopedics and Sports Medicine 22
- General Health Professions 60
Countries citing papers authored by Susan Cornell
This map shows the geographic impact of Susan Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Cornell more than expected).
Fields of papers citing papers by Susan Cornell
This network shows the impact of papers produced by Susan Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Cornell. The network helps show where Susan Cornell may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Cornell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 100 | |
| 2 | 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase. | 1996 | 50 |
| 3 | 2012 | 39 | |
| 4 | 2015 | 36 | |
| 5 | 2012 | 33 | |
| 6 | 2013 | 32 | |
| 7 | 2017 | 29 | |
| 8 | 1993 | 28 | |
| 9 | 2015 | 23 | |
| 10 | 2004 | 17 | |
| 11 | 2012 | 14 | |
| 12 | 2004 | 9 | |
| 13 | 2011 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2010 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2013 | 4 | |
| 18 | 2022 | 2 | |
| 19 | 2006 | 2 | |
| 20 | 2024 | 1 |
About Susan Cornell
Susan Cornell is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and General Health Professions, having authored 24 papers that have together received 443 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers), Metabolism, Diabetes, and Cancer (4 papers), Pharmacology and Obesity Treatment (4 papers), Pancreatic function and diabetes (3 papers), Diet and metabolism studies (3 papers), Computational Drug Discovery Methods (2 papers) and Interprofessional Education and Collaboration (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (212 citations), Geriatrics and Gerontology (19 citations), Pharmacology (55 citations), Orthopedics and Sports Medicine (22 citations) and General Health Professions (60 citations). Susan Cornell has collaborated with scholars based in United States, Italy and Ireland. Frequent co-authors include Mark H. Perrone, Dilip Amin, Glenda E. Bilder, Curtis Triplitt, Lon J. Van Winkle, Sophie La Salle, Susan M. Viselli, Nalini Chandar, Sean M. Lynch and Jacalyn M. Green. Their work appears in journals such as Journal of the American Pharmacists Association, American Journal of Pharmaceutical Education, Pharmacology, Therapeutics and Clinical Risk Management and Health Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.